Nicola Fusco, Director of the Division of Pathology at IEO European Institute of Oncology, shared a post on LinkedIn:
“Sometimes pathology changes lives in ways we don’t expect.
Not only for patients.
But also for those who care for their diagnoses.
For those who study, test biomarkers, and fight every day to understand a disease before it strikes again.
Liquid biopsy is one of those revolutions.
It gives patients time, the most precious variable we have.
It gives oncologists clarity when decisions are hard.
It gives pathologists purpose, turning drops of blood into stories of resistance, hope, and discovery.
This week, part of my team joined the International Society of Liquid Biopsy Meeting in Orlando, FL, celebrating not only ctDNA but also community.
A community that grows, inspires, and connects people across continents and disciplines.
And it was truly special to see my mate Umberto Malapelle appointed as the new President of the International Society of Liquid Biopsy, a recognition for his passion and vision.
Proud of the journey we are all making together.
From pathology to clinics.
From ctDNA to biomarkers.”
More posts featuring Nicola Fusco.
